|
|
|
Volumn 23, Issue 4, 2011, Pages 14-18
|
|
Rilpivirine and complera: new first-line treatment options.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE PLUS RILPIVIRINE PLUS TENOFOVIR DISOPROXIL;
NITRILE;
PHOSPHONIC ACID DERIVATIVE;
PYRIMIDINE DERIVATIVE;
RILPIVIRINE;
ARTICLE;
CLINICAL TRIAL (TOPIC);
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
ADENINE;
ANTI-HIV AGENTS;
CLINICAL TRIALS AS TOPIC;
DEOXYCYTIDINE;
HIV INFECTIONS;
HUMANS;
NITRILES;
PHOSPHONIC ACIDS;
PYRIMIDINES;
|
|
EID: 84861419155
PISSN: 1058708X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
